Kewalramani Reshma's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed May 1, 2023
- Accession no.
- 0001209191-23-026270
- Filed
- May 1, 2023
- Trade date
- Apr 27, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $1.12M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kewalramani ReshmaCIK 0001735944 | Director, Officer (CEO & President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 27, 2023 | Common Stock | SSaleDisposed | −1,611 | $338.69F2,F3 | −$545,629.59 | 128,358 | Direct | |
| Apr 27, 2023 | Common Stock | SSaleDisposed | −1,668 | $339.43F2,F4 | −$566,169.24 | 126,690 | Direct | |
| Apr 27, 2023 | Common Stock | SSaleDisposed | −38 | $340.19 | −$12,927.22 | 126,652 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 2 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $338.69 (range $338.00 to $338.99).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $339.43 (range $339.00 to $339.98).
Referenced by the price of 1 transaction in Table I.